Peptide record

TPDB43461

Antiviral standard
35 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43461
Antiviral
Anti-infective peptides
AI4AVP Peptipedia
standard
No
A 35-aa standard-residue antiviral peptide sequence curated from AI4AVP and Peptipedia, with an available 3D structural model.
Sequence
GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C167H286N48O57
CHMFPTWY
NL
3878.39
4.44
4
6
14
-2
1.87
-0.311
130.86
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
9
Residue Composition
number
2
A
1
R
5
N
2
D
0
C
4
E
2
Q
2
G
0
H
4
I
5
L
3
K
0
M
0
F
0
P
2
S
0
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 2 R: 1 N: 5 D: 2 C: 0 E: 4 Q: 2 G: 2 H: 0 I: 4 L: 5 K: 3 M: 0 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 3
Chemical Descriptors
35 reviewed residue count
C167H286N48O57 sequence-only estimate (linear, free termini)
3878.39 sequence-only estimate (linear, free termini)
4.44 sequence-only estimate (linear, free termini)
-2 sequence-only estimate (linear, free termini)
1.87 sequence-only estimate (linear, free termini)
-0.311 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA